Table 2. Results of the baseline cost-effectiveness analysis.
Name of the Strategy | Costs (US dollars) | Effectiveness (DALYS) | Average C-E Ratio¥ | Incremental Costs | Incremental Effectiveness(Averted DALYS) | Incremental C-E Ratio ∞ |
---|---|---|---|---|---|---|
No Vaccination | 551 | 3.483 | 158 | |||
Quadrivalent Vaccine | 688 | 3.478 | 198 | 137 | 0.00563 | 24241 |
Bivalent vaccine | 713 | 3.478 | 205 | 162 | 0.00563 | 28765 |
¥ Strategy costs divided by DALYS
∞ Strategy Costs - ‘No vaccination’ Costs / ‘No vaccination’ DALYS - Strategy DALYS